Covance
Contact Us   |  Client Login  

  • PRODUCTS & SERVICES
    • Antibody Products
      • Antibody Products Store
      • Neuroscience
      • Epitope Tags
      • Structural Proteins & Cell Components
      • Signal Transduction
      • Immunopathology
      • Detection Chemistries & Ancillaries
      • Custom Immunology Services
    • Clinical Services
      • Bioanalytical
      • Central Laboratory
      • Clinical Development (Phase I-III)
    • Discovery & Translational Services
      • Antibody Products
      • Biomarker Center of Excellence
      • BioPathways
      • Computational Biology
      • Genomics Laboratory
      • Immunology
      • Lead Optimization
      • Vaccines & Infectious Disease
    • Nonclinical Services
      • Antibody Products
      • Bioanalytical Services
      • Drug Metabolism & Pharmacokinetics
      • Immunology
      • Lead Optimization
      • Radiosynthesis
      • Research Models
      • Safety Pharmacology
      • Toxicology
      • Vaccines & Infectious Disease
    • Biopharmaceutical CMC Solutions
    • Biorepository Services
    • Environmental Sciences
    • Genomics Laboratory
    • Integration in Drug Development
    • Market Access
    • Nutritional Chemistry & Food Safety
    • Secure Data Access
    • Strategic Partnering

  • CAREERS
    • Search Jobs
    • College / University
    • Featured Jobs
    • Diversity
    • Benefits
    • 现在就加入科文斯

  • STUDY PARTICIPANTS

  • INVESTORS
    • Investor Information
      • Investor Home
      • Stock Information
      • Board of Directors
      • Corporate Governance Guidelines
      • Analyst Coverage
      • Investor FAQ
      • Presentations & Webcasts
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Press Releases
    • Calendar of Events
    • Request Information

  • NEWS
    • Press Releases
    • Media Relations

  • ABOUT COVANCE
    • Company Overview
    • Industry Overview
    • History of Covance
    • Mission & Vision
    • Global Locations
    • Executive Leadership
    • Events
    • Corporate Responsibility
    • Supplier Code of Conduct
    • Business Integrity Program
    • Animal Welfare
    • Covance.Asia

  • RESOURCE CENTER
    • Blog
Investors
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
Calendar of Events
Request Information
Home > Investors > Investor Information
Investor Relations
Investor Information
CVD
Exchange NYSE (US Dollar)
Price $75.71
Change (%)  -0.81 (-1.06)
Volume 42,441
Data as of May 24 2013 10:51AM
Minimum 20 minute delay


Annual Meeting Documents
2012 Annual Report
2013 Notice of Annual Meeting & Proxy Statement


Upcoming & Current Events
There are currently no events scheduled.


Recent Covance News More >>  
DateTitle
21-May-2013Covance Testing Method Named Industry Standard Print
13-May-2013Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference Print
06-May-2013Covance To Present At The R. W. Baird 2013 Growth Stock Conference Print
01-May-2013Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million Print


Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2013 Covance Inc. All rights reserved.